Brainomix entered the US market in 2023 having gained several FDA clearances for modules within its stroke care platform.

Oxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for ...

Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...

Recent data shows that 75,000 businesses and 56,000 jobs in Alabama benefit from using TikTok, with 45% saying the platform ...

Oxford BioTherapeutics (OBT) has lined up another big pharma partner for its drug discovery platform, agreeing to work with ...

Oxford Biotherapeutics Ltd. is partnering with Roche AG to expand the current field of tumor antigens that can be drugged with antibodies, as part of a potential $1 billion-plus agreement. The ...

Britain’s foreign intelligence agency has launched a search for its next chief and the current officeholder has suggested ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Democratic voters want the party to take a firmer line in Congress, even if it leads to gridlock, according to a new poll.

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...